Searching across hundreds of databases
Dravet syndrome (DS) is an infantile epileptic encephalopathy mainly caused by de novo mutations in the SCN1A gene encoding the α1 subunit of the voltage-gated sodium channel Nav1.1. As an in vitro model of this disease, we previously generated an induced pluripotent stem cell (iPSC) line from a patient with DS carrying a c.4933C>T (p.R1645*) substitution in SCN1A. Here, we describe developing a genome-edited control cell line from this DS iPSC line by substituting the point mutation with the wild-type residue. This artificial control iPSC line will be a powerful tool for research into the pathology of DS.
Pubmed ID: 29453127 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This monoclonal targets HSP90B1
View all literature mentionsThis monoclonal targets TRA-1-81 clone TRA-1-81
View all literature mentionsThis monoclonal targets Smooth Muscle Actin
View all literature mentionsThis monoclonal targets alpha-Fetoprotein
View all literature mentionsThis monoclonal targets β-Tubulin III
View all literature mentionsThis monoclonal targets SSEA-4
View all literature mentionsThis monoclonal targets Stage-Specific Embryonic Antigen-4
View all literature mentionsSoftware for single-cell flow cytometry analysis. Its functions include management, display, manipulation, analysis and publication of the data stream produced by flow and mass cytometers.
View all literature mentionsThis monoclonal targets TRA-1-81 clone TRA-1-81
View all literature mentionsThis monoclonal targets HSP90B1
View all literature mentionsThis monoclonal targets HSP90B1
View all literature mentionsThis monoclonal targets TRA-1-81 clone TRA-1-81
View all literature mentionsThe SciCrunch Infrastructure was developed as a cooperative data platform to be used by diverse communities in making data more FAIR.
scicrunch.org
